Dr. Pasi A. Jänne MD, PhD
Research Technician
Dr. Pasi A. Jänne MD, PhD, (Pasi_Janne@dfci.harvard.edu) is a translational thoracic medical oncologist at the Dana-Farber Cancer Institute and a professor of medicine at Harvard Medical School. He is the director of the Lowe Center for Thoracic Oncology and the scientific co-director of the Belfer Center for Applied Cancer Sciences. After earning his MD and PhD from the School of Medicine at the University of Pennsylvania, Dr. Jänne completed his internship and residency in medicine at Brigham and Women’s Hospital.
He completed fellowship training in 2001 at the Dana-Farber Cancer Institute/Massachusetts General Hospital combined program in medical oncology. He earned a master’s degree in clinical investigation from Harvard University in 2002.
Dr. Jänne has received several awards for his research, including from Uniting Against Lung Cancer, American Lung Association, and the Bonnie J. Addario Lung Cancer Foundation. He is an elected member to the American Society of Clinical Investigation (2008), American Association of Physicians (2016), and the Finnish Academy of Science and Letters (2016). Dr. Jänne is the recipient of 2010 American Association of Cancer Research Richard and Hinda Rosenthal Memorial Award and a member of the 2010 AACR Team Science Award, American Cancer Research Clinical Research Professorship (2017), Waun Ki Hong Award for Outstanding Achievement in Translational and Clinical Cancer Research from the American Association for Cancer Research (2018), Translational Research Awardfrom the European Society for Medical Oncology (2018), R35 – Outstanding Investigator Award from the National Cancer Institute (2018), and Science of Oncology Award from the American Society of Clinical Oncology (2020).
Dr. Pasi A. Jänne MD, PhD
Research Technician
Dr. Pasi A. Jänne MD, PhD, (Pasi_Janne@dfci.harvard.edu) is a translational thoracic medical oncologist at the Dana-Farber Cancer Institute and a professor of medicine at Harvard Medical School. He is the director of the Lowe Center for Thoracic Oncology and the scientific co-director of the Belfer Center for Applied Cancer Sciences. After earning his MD and PhD from the School of Medicine at the University of Pennsylvania, Dr. Jänne completed his internship and residency in medicine at Brigham and Women’s Hospital.
He completed fellowship training in 2001 at the Dana-Farber Cancer Institute/Massachusetts General Hospital combined program in medical oncology. He earned a master’s degree in clinical investigation from Harvard University in 2002.
Dr. Jänne has received several awards for his research, including from Uniting Against Lung Cancer, American Lung Association, and the Bonnie J. Addario Lung Cancer Foundation. He is an elected member to the American Society of Clinical Investigation (2008), American Association of Physicians (2016), and the Finnish Academy of Science and Letters (2016). Dr. Jänne is the recipient of 2010 American Association of Cancer Research Richard and Hinda Rosenthal Memorial Award and a member of the 2010 AACR Team Science Award, American Cancer Research Clinical Research Professorship (2017), Waun Ki Hong Award for Outstanding Achievement in Translational and Clinical Cancer Research from the American Association for Cancer Research (2018), Translational Research Awardfrom the European Society for Medical Oncology (2018), R35 – Outstanding Investigator Award from the National Cancer Institute (2018), and Science of Oncology Award from the American Society of Clinical Oncology (2020).
Maisam Makarem, MD, PhD
Clinical Fellow
(Jie_Jiang@dfci.harvard.edu) is a cancer chemical biologist. Her studies focus on the development of small-molecule kinase inhibitors and targeted protein degraders as novel therapeutics to deliver new solutions for cancers that resist current therapies. Yorem ipsum dolor sit amet, consectetur adipiscing elit. Etiam eu turpis molestie, dictum est a, mattis tellus. Sed dignissim, metus nec fringilla accumsan, risus sem sollicitudin lacus, ut interdum tellus elit sed risus. Maecenas eget condimentum velit, sit amet feugiat lectus. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Praesent auctor purus luctus enim egestas, ac scelerisque ante pulvinar. Donec ut rhoncus ex. Suspendisse ac rhoncus nisl, eu tempor urna. Curabitur vel bibendum lorem. Morbi convallis convallis diam sit amet lacinia. Aliquam in elementum tellus.
Curabitur tempor quis eros tempus lacinia. Nam bibendum pellentesque quam a convallis. Sed ut vulputate nisi. Integer in felis sed leo vestibulum venenatis. Suspendisse quis arcu sem. Aenean feugiat ex eu vestibulum vestibulum. Morbi a eleifend magna. Nam metus lacus, porttitor eu mauris a, blandit ultrices nibh. Mauris sit amet magna non ligula vestibulum eleifend. Nulla varius volutpat turpis sed lacinia. Nam eget mi in purus lobortis eleifend. Sed nec ante dictum sem condimentum ullamcorper quis venenatis nisi. Proin vitae facilisis nisi, ac posuere leo.
Nam pulvinar blandit velit, id condimentum diam faucibus at. Aliquam lacus nisi, sollicitudin at nisi nec, fermentum congue felis. Quisque mauris dolor, fringilla sed tincidunt ac, finibus non odio. Sed vitae mauris nec ante pretium finibus. Donec nisl neque, pharetra ac elit eu, faucibus aliquam ligula. Nullam dictum, tellus tincidunt tempor laoreet, nibh elit sollicitudin felis, eget feugiat sapien diam nec nisl. Aenean gravida turpis nisi, consequat dictum risus dapibus a. Duis felis ante, varius in neque eu, tempor suscipit sem. Maecenas ullamcorper gravida sem sit amet cursus. Etiam pulvinar purus vitae justo pharetra consequat. Mauris id mi ut arcu feugiat maximus. Mauris consequat tellus id tempus aliquet.Maisam Makarem, MD, PhD
Clinical Fellow
(Jie_Jiang@dfci.harvard.edu) is a cancer chemical biologist. Her studies focus on the development of small-molecule kinase inhibitors and targeted protein degraders as novel therapeutics to deliver new solutions for cancers that resist current therapies. Yorem ipsum dolor sit amet, consectetur adipiscing elit. Etiam eu turpis molestie, dictum est a, mattis tellus. Sed dignissim, metus nec fringilla accumsan, risus sem sollicitudin lacus, ut interdum tellus elit sed risus. Maecenas eget condimentum velit, sit amet feugiat lectus. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Praesent auctor purus luctus enim egestas, ac scelerisque ante pulvinar. Donec ut rhoncus ex. Suspendisse ac rhoncus nisl, eu tempor urna. Curabitur vel bibendum lorem. Morbi convallis convallis diam sit amet lacinia. Aliquam in elementum tellus.
Curabitur tempor quis eros tempus lacinia. Nam bibendum pellentesque quam a convallis. Sed ut vulputate nisi. Integer in felis sed leo vestibulum venenatis. Suspendisse quis arcu sem. Aenean feugiat ex eu vestibulum vestibulum. Morbi a eleifend magna. Nam metus lacus, porttitor eu mauris a, blandit ultrices nibh. Mauris sit amet magna non ligula vestibulum eleifend. Nulla varius volutpat turpis sed lacinia. Nam eget mi in purus lobortis eleifend. Sed nec ante dictum sem condimentum ullamcorper quis venenatis nisi. Proin vitae facilisis nisi, ac posuere leo.
Nam pulvinar blandit velit, id condimentum diam faucibus at. Aliquam lacus nisi, sollicitudin at nisi nec, fermentum congue felis. Quisque mauris dolor, fringilla sed tincidunt ac, finibus non odio. Sed vitae mauris nec ante pretium finibus. Donec nisl neque, pharetra ac elit eu, faucibus aliquam ligula. Nullam dictum, tellus tincidunt tempor laoreet, nibh elit sollicitudin felis, eget feugiat sapien diam nec nisl. Aenean gravida turpis nisi, consequat dictum risus dapibus a. Duis felis ante, varius in neque eu, tempor suscipit sem. Maecenas ullamcorper gravida sem sit amet cursus. Etiam pulvinar purus vitae justo pharetra consequat. Mauris id mi ut arcu feugiat maximus. Mauris consequat tellus id tempus aliquet.
team-testadmin2025-03-20T15:44:35+00:00